Trial intelligence / Profile preview

Tranexamic acid for reducing blood loss after vaginal delivery

PACTR202502681244416Recruiting

Sponsor
Okoko Fiafiata
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in postpartum hemorrhage (PPH) comparing Tranexamic acid injection group with Placebo group (2 arms). Primary endpoints: Estimated blood loss following vaginal delivery and Difference in haematocrit at 24 hours. Started Dec 2024; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on PACTR202502681244416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202502681244416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call